Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

ERBA MANNHEIM

Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App





Erba Mannheim Makes SARS-CoV-2 Testing Available to Labs Everywhere

By LabMedica International staff writers
Posted on 03 Jul 2020
Erba Mannheim (London, England) has taken up the challenge of providing labs and clinicians everywhere with reliable and affordable solutions to SARS-CoV-2 testing.

The company’s efforts come amidst the serious challenges in the supply of material related to sampling and testing of SARS-CoV-2, as well as public confusion over the utility of some types of test. More...
With two main technologies emerging for SARS-CoV-2 testing: molecular (primarily PCR) and serology (ELISA, rapid tests, IFA), Erba has joined the fight against COVID-19 by launching the ErbaLisa IgG and IgM antibody ELISA kits. These tests have been developed and manufactured entirely in California, US by Calbiotech, the immunoassay center of excellence of the Erba Mannheim group.

Similar to its ErbaLisa ELISA range, Erba has continued to maintain quality and performance as the top priorities for its COVID-19 antibody assays. The IgG kits use Spike protein antigens to ensure clinical relevance and specificity, and the IgM kits employ a combination of Spike and Nucleocapsid antigens. Additionally, Erba has extensively validated the performance and accuracy of these tests through multiple studies in partnership with public and private laboratories, as well as universities. Aside from being CE marked, and pending EUA authorization in the US, the ErbaLisa COVID-19 tests have also been approved by strict regulatory bodies across the globe, from ANVISA in Brazil to the ICMR in India.

In addition to ensuring quality and performance of its ErbaLisa COVID-19 tests, Erba is now focusing on making these tests available to labs everywhere. The company remains committed to making quality diagnostic solutions affordable to growing labs across all the emerging markets in Asia, Latin America, the Middle East and Africa. Amidst the ongoing challenges in supply of reliable COVID-19 tests and long-standing IVD companies giving higher priority to meeting the demand in Europe and North America, Erba’s commitment to the emerging markets assumes greater significance.



Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Collection and Transport System
PurSafe Plus®
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
New
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.